Recall: D-0877-2026

Class II - Potentially Harmful

Class IIClassification
2026-09-23Initiated
OngoingStatus
Apotex Corp.Firm

Product

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

Reason

Failed dissolution specifications.

Distribution

US Nationwide.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.